SEC 13F Intelligence

Bridge City Capital, LLC / CN2

Bridge City Capital, LLC’s Catalyst Pharmaceuticals Inc Position

Does Bridge City Capital, LLC own Catalyst Pharmaceuticals Inc (CN2)? Yes — 155.7K shares worth $4M (+1.07% of its 13F portfolio) as of Q1 2026, down from 156.7K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
155.7K
% of Portfolio
+1.07%
Quarters Held
5
currently held

Position History CN2

Reported value by quarter
Q1 ’25: $3MQ1 ’25Q2 ’25: $3MQ2 ’25Q3 ’25: $4MQ3 ’25Q4 ’25: $4MQ4 ’25Q1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026155.7K$4M+1.07%
Q4 2025156.7K$4M+1.07%
Q3 2025182.3K$4M+0.96%
Q2 2025115.9K$3M+0.71%
Q1 2025117.4K$3M+0.85%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridge City Capital, LLC’s full portfolio or all institutional holders of CN2.